Public Company Healthcare

Waters Corporation

Milford, Massachusetts, United States

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service—focused on regulated, high-volume testing environments to help advance the release of high-quality medicines and improve human health and well-being.

Focus Areas
Analytical instrumentation, Laboratory informatics, Mass spectrometry
Website
www.waters.com

Tracked deals

3

3 tracked deals across 2004-2025.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

3 buyout

Waters Corporation Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for Waters Corporation. 1 2023 1 2025

Supporting Data

Recent Transactions

  • Buyer
    Waters Corporation
    Target
    Halo Labs
    Industry
    Medical Devices
    Type
    Buyout

    Waters Corporation has acquired Halo Labs, a venture-backed developer of the Aura imaging platform for subvisible and visible particle analysis used in cell, gene and protein therapy development and QA/QC. The deal brings Halo Labs' high-throughput, low-volume particle analysis technology into Waters' Wyatt Technology portfolio to expand Waters' analytical and bioprocessing testing capabilities for large-molecule therapies.

  • Buyer
    Waters Corporation
    Target
    Wyatt Technology
    Industry
    Medical Devices
    Type
    Buyout

    Waters Corporation agreed to acquire Wyatt Technology, a leader in light scattering instruments, software and related services, for $1.36 billion in cash. The acquisition (expected to close in Q2 2023) expands Waters' capabilities and exposure to bioanalytical characterization and large-molecule applications; Wyatt reported ~ $110 million in 2022 revenue and employs more than 200 people worldwide.

  • Buyer
    Waters Corporation
    Target
    NuGenesis Technologies
    Industry
    Software
    Type
    Buyout

    Waters Corporation completed the acquisition of NuGenesis Technologies, a Westborough, Massachusetts-based developer of laboratory informatics and SDMS products, for approximately $43 million. The purchase expands Waters' informatics product portfolio and strengthens its offering for scientific and pharmaceutical laboratories.

Related Acquisition Pages

Selling a company? Get in front of buyers like Waters Corporation

Turn tracked acquisition activity into an outreach-ready buyer list.